SVG Sprites

Press

Press Releases 12.06.2021

Senate must heed Biden’s call to pass Rx pricing reform

Lowering prescription drug prices is one of the most immediate and significant ways we can help families currently struggling with high costs. President Biden’s focus on lowering costs for seniors, people who rely on insulin, and working families is critically important to making sure the Build Back Better Act passes quickly.

Press Releases 11.19.2021

BBB Act passes House, establishing a foundation for drug pricing reform

The House’s passage of the Build Back Better Act is a significant first step toward breaking up Pharma’s monopoly power over prices and making medicines more affordable for millions. 

LDPN in the News 11.16.2021

Rx companies continue price gouging Americans

It is absolutely ridiculous that at the same time Big Pharma is spending literally hundreds of millions of dollars to try and stop lawmakers from lowering prescription drug prices for families, they’re also raising prices of the most expensive drugs in the U.S. to inflate profits.

Press Releases 11.03.2021

Rx drug deal is welcome news

Reports that Democrats in Congress have stepped back from the legislative and political abyss by deciding to include prescription drug reform in the Build Back Better plan is welcome news. Not only has poll after poll shown that this is a top concern for voters, but Democrats have been campaigning and winning on this issue for years. 

Press Releases 10.28.2021

Build Back Better is insufficient without Rx pricing reform

While some parts of the Build Back Better framework may be historic, without meaningful prescription drug reform that enables the federal government to negotiate lower prices we cannot truly build back better as a nation. 

LDPN in the News 10.07.2021

Statesman Journal: The problem with Rep. Schrader’s shifting priorities on lowering drug prices

Congress is debating legislation right now that would lower drug prices, cap out-of-pocket costs and save American taxpayers hundreds of billions of dollars over the next decade.

Press Releases 09.15.2021

Big Pharma’s fans in Congress stall Rx pricing reform

Big Pharma is fighting this reform for one reason and one reason only: to protect their sky-high profits and lavish CEO pay. Their army of lobbyists may have bought off enough politicians to win this vote, but they won’t have the final say. 

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles